Foghorn Therapeutics Inc (FHTX)
NASDAQ
Quarter End | 9 2022 | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
総売上 | 6.63M | 4.18M | 5.31M | 5.6M | 17.48M | 5.77M | 5.05M | 6.89M |
営業利益 | -28.26M | -31.89M | -33.32M | -32.05M | -17.08M | -30.78M | -28.19M | -26.63M |
税引前収入 | -25.77M | -28.89M | -29.93M | -28.55M | -13.61M | -22.12M | -25.02M | -22.98M |
純利益 | -25.77M | -28.89M | -30.49M | -29.49M | -14.35M | -24.11M | -25.02M | -22.98M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -28.26M | -29.31M | -32.6M | -31.34M | -16.36M | -30.1M | -27.46M | -25.85M |
EBITDA | -27.42M | -31.04M | -32.46M | -31.17M | -16.22M | -29.93M | -27.36M | -23.44M |
年末 2023年12月31日 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 430k | 1.32M | 19.23M | 34.16M |
営業利益 | -26.05M | -51.08M | -68.53M | -100.73M | -117.14M | -107.91M |
税引前収入 | -26.34M | -51.13M | -68.8M | -101.32M | -108.88M | -94.2M |
純利益 | -26.34M | -51.13M | -68.8M | -101.32M | -108.88M | -98.43M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -4.097 | -5.674 | -1.87 | -2.453 | -2.605 | -2.331 |
EBIT | -26.05M | -51.08M | -68.75M | -101.97M | -114.56M | -105.08M |
EBITDA | -25.67M | -50.39M | -67.2M | -97.51M | -113.82M | -104.46M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約